GMP Testing Service Market by Service Type (Packaging and Shelf-life Testing, Product Validation Testing, Bioanalytical Services, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies), and Region 2023-2028

GMP Testing Service Market by Service Type (Packaging and Shelf-life Testing, Product Validation Testing, Bioanalytical Services, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies), and Region 2023-2028


Market Overview:

The global GMP testing service market size reached US$ 1.43 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.08 Billion by 2028, exhibiting a growth rate (CAGR) of 6.12% during 2023-2028. The surging pharmaceutical production, expanding prevalence of chronic diseases, and ongoing technological advancements represent some of the key factors driving the market.

Good Manufacturing Practice (GMP) testing service refers to the set of quality control procedures and requirements. Companies involved in the manufacturing, testing, and distribution of pharmaceuticals, medical devices, and other products regulated by various regulatory bodies, such as the Food and Drug Administration (FDA), are required to follow these procedures. GMP testing service is an essential part of the drug development process, ensuring that products are safe, effective, and of high quality. It typically includes a range of analytical and microbiological testing, including potency, purity, stability, and sterility testing. These tests are performed at various stages of the drug development process, including sourcing raw materials and quality-checking the finished products. They are designed to ensure the product is manufactured according to established standards and specifications.

GMP Testing Service Market Trends:



The rising development of biosimilars, combination drugs, and other innovative medicines is fueling the demand for specific testing procedures, such as GMP testing services. Besides this, the escalating demand for drugs, vaccines, and other pharmaceuticals due to the rising prevalence of chronic diseases caused by aging populations, sedentary lifestyles, unhealthy dietary habits, and various environmental risk factors is creating a positive outlook for the market. Moreover, different biopharmaceutical companies are outsourcing bioanalytical testing services for drug development and validation at both clinical and preclinical stages, which, in turn, is propelling the market growth. Concurrent with this, the rise in patent expiration of generic and branded drug compounds is impelling manufacturers to conduct and submit bioanalytical testing results, which is contributing to the market growth. In addition to this, the increasing number of stringent regulatory requirements imposed by various regulatory bodies for the quality control and testing of pharmaceutical products are presenting remunerative growth opportunities for the market. Furthermore, innovative technological advancements in GMP testing services, such as the advent of chromatography, spectroscopy, and spectrometry, have led to more accurate and efficient testing of pharmaceutical products, which is acting as another significant growth-inducing factor.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global GMP testing service market, along with forecasts at the global levels from 2023-2028. Our report has categorized the market based on service type and end user.

Service Type Insights:

Packaging and Shelf-life Testing
Product Validation Testing
Bioanalytical Services
Others

The report has provided a detailed breakup and analysis of the GMP testing service market based on the service type. This includes packaging and shelf-life testing, product validation testing, bioanalytical services, and others. According to the report, product validation testing represented the largest segment.

End User Insights:

Pharmaceutical and Biopharmaceutical Companies
Medical Device Companies

A detailed breakup and analysis of the GMP testing service market based on the end user has also been provided in the report. This includes pharmaceutical and biopharmaceutical companies and medical device companies. According to the report, pharmaceutical and biopharmaceutical companies accounted for the largest market share.

Regional Insights:

North America

United States
Canada

Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others

Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others

Latin America

Brazil
Mexico
Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for GMP testing service. Some of the factors driving the North America GMP testing service market included the rising demand for various drugs and medicines, the growing prevalence of chronic diseases, and innovative technological advancements in the industry.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global GMP testing service market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Almac Group, Charles River Laboratories International Inc., Eurofins Scientific SE, ICON plc, Intertek Group plc, Merck KgaA, Nelson Laboratories LLC (Sotera Health Company), North American Science Associates LLC, Pace Analytical Services LLC, PPD Inc. (Thermo Fisher Scientific Inc.), Sartorius AG, Wuxi Apptec Co. Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

How has the global GMP testing service market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global GMP testing service market?
What is the impact of each driver, restraint, and opportunity on the global GMP testing service market?
What are the key regional markets?
Which countries represent the most attractive GMP testing service market?
What is the breakup of the market based on the service type?
Which is the most attractive service type in the GMP testing service market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the GMP testing service market?
What is the competitive structure of the global GMP testing service market?
Who are the key players/companies in the global GMP testing service market?


1 Preface
2 Scope and Methodology
  2.1 Objectives of the Study
  2.2 Stakeholders
  2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
  2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
  2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
  4.1 Overview
  4.2 Key Industry Trends
5 Global GMP Testing Service Market
  5.1 Market Overview
  5.2 Market Performance
  5.3 Impact of COVID-19
  5.4 Market Forecast
6 Market Breakup by Service Type
  6.1 Packaging and Shelf-Life Testing
6.1.1 Market Trends
6.1.2 Market Forecast
  6.2 Product Validation Testing
6.2.1 Market Trends
6.2.2 Market Forecast
  6.3 Bioanalytical Services
6.3.1 Market Trends
6.3.2 Market Forecast
  6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by End User
  7.1 Pharmaceutical and Biopharmaceutical Companies
7.1.1 Market Trends
7.1.2 Market Forecast
  7.2 Medical Device Companies
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Region
  8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
  8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
  8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
  8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
  8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
  9.1 Overview
  9.2 Drivers
  9.3 Restraints
  9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
  11.1 Overview
  11.2 Bargaining Power of Buyers
  11.3 Bargaining Power of Suppliers
  11.4 Degree of Competition
  11.5 Threat of New Entrants
  11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
  13.1 Market Structure
  13.2 Key Players
  13.3 Profiles of Key Players
13.3.1 Almac Group 
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 SWOT Analysis
13.3.2 Charles River Laboratories International Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Eurofins Scientific SE
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 ICON plc
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Intertek Group plc
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Merck KgaA
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Nelson Laboratories LLC (Sotera Health Company)
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 North American Science Associates LLC
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Pace Analytical Services LLC
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.10 PPD Inc. (Thermo Fisher Scientific Inc.)
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11 Sartorius AG
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Wuxi Apptec Co. Ltd.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 FinancialsKindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings